ProCE Banner Activity

What the Pandemic Can Teach Us About HCV Care Among People Who Inject Drugs

Clinical Thought
Here’s my take on how healthcare developments from the COVID-19 pandemic and simplified HCV screening, treatment, and monitoring can improve management for underserved populations.

Released: November 08, 2021

Expiration: November 07, 2022

No longer available for credit.

Share

Faculty

Gregory Dore

Gregory Dore, MBBS, PhD, FRACP, MPH

Professor, Head
Viral Hepatitis Clinical Research Program
Kirby Institute
University of New South Wales
Professor
Infectious Diseases Physician
St Vincents Hospital
Sydney, Australia

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Educational grants provided by:

AbbVie

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Gregory Dore, MBBS, PhD, FRACP, MPH

Professor, Head
Viral Hepatitis Clinical Research Program
Kirby Institute
University of New South Wales
Professor
Infectious Diseases Physician
St Vincents Hospital
Sydney, Australia

Gregory Dore, MBBS, PhD, FRACP, MPH, has no relevant conflicts of interest to report.